The presence of replication-competent retrovirus (RCR) in retroviral-based gene therapy products poses a potential safety risk for patients. Therefore, RCR testing of clinical gene therapy products and monitoring of patients enrolled in gene therapy trials is required to assure viral safety. The requirement to test ex vivo-transduced cells originates from the presumed amplification of adventitious RCR during the transduction procedure. However, data on the capacity of different cell types to do so are lacking. In this study, we sought to analyze the amplification potential of primary human T lymphocytes after infection with amphotropic MLVbased RCR. The total number of viral particles produced after 1 or 2 weeks was measured by a quantitative 4070A env-specific RT-PCR assay. The fraction of infectious replication-competent viral particles was analyzed in the PG-4 S þ L-assay. From this study, we conclude that the total number of viral particles RCR produced by T lymphocytes is 2-4 logs lower than the number produced by NIH-3T3 cells. Surprisingly, less than 1% of the viral particles produced by primary T lymphocytes appeared to be infectious, while nearly all virions produced by NIH-3T3 were. We conclude that primary human T lymphocytes are low producers of MLV-based amphotropic RCR.
Introduction
Recombinant retroviral vectors based on Moloney murine leukemia virus (MLV) are predominant delivery systems in human gene therapy protocols. Replication-competent retrovirus (RCR) may arise during the production of recombinant retroviral supernatants. To minimize the risk of recombination between helper and recombinant plasmids, third-generation packaging cell lines (eg GP þ AM12) were developed that contain split function helper constructs and minimal sequence overlap between helper and recombinant constructs. 1 Despite these precautions the incidental generation of RCR by thirdgeneration packaging cell lines has been reported. [2] [3] [4] [5] Even though it is generally agreed that contamination of retroviral gene therapy products with RCR is unwanted, data on the biological risk of RCR in primates are scarce. The risk of murine amphotropic retroviruses in primates has been studied in two reports. In one study, no pathology was observed after infusion of RCR into three normal and two immune-suppressed rhesus monkeys, probably because of a rapid clearance of virus from the circulation. 6, 7 However, in a seminal report, Donahue et al 8 infused ex vivo-transduced hematopoietic stem cells into 10 immune-suppressed rhesus macaques. The recombinant virus was produced in the secondgeneration packaging cell line PA317, which was known to produce low amounts of RCR (10 3 -10 4 /ml). In the course of their experiments, these authors observed induction of aggressive lymphoma by their vector in three animals. In the two animals analyzed, RCR was detected in plasma at titers of 10 4 and 10
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, respectively. Additional studies revealed that various RCR had arisen through recombination between the recombinant construct and helper and/or endogenous retroviral sequences in the PA317 packaging cell line. 9, 10 No antiviral Ab could be detected in these animals, in contrast to the seven unaffected animals. These data suggest that the inability of the affected animals to mount a proper Ab response played a crucial role in spreading of the virus. Involvement of RCR in the induction of the lymphoma came from the finding that the lymphoma cells contained high copy numbers (10-450) of proviral DNA. The tumor cells of one analyzed animal even produced RCR. These data indicate that great vigilance should be exercised to exclude the transfer of unanticipated RCR to (immune-suppressed) patients. Therefore, the FDA has issued a guideline, which prescribes testing of retroviral supernatants for the presence of RCR. In addition, ex vivo-transduced cells need to be tested, if the transduction procedure takes more than 3 days. The latter requirement is based on the assumption that a single contaminating RCR will be amplified during this culture period.
At present, it is unknown to what extent the origin of the infected cell affects its capacity to produce RCR. In particular, data on the capacity of primary T lymphocytes, a frequent target in gene therapy protocols, to amplify RCR are scarce. In preparation of a protocol for the treatment of patients with retrovirally transduced T lymphocytes, we wished to make a risk assessment of exposure of primary T lymphocytes to amphotropic MLV-based RCR. We used two assays to measure RCR: an RT-PCR assay, which detects all amphotropic viral particles and the PG-4 S þ L-biological assay to measure only those amphotropic viral particles that are able to infect target cells (and thus propagate). We developed and validated a real-time RT-PCR assay, that detects the 4070A amphotropic envelope gene. With this assay we were able to detect a single RCR. We performed several experiments in which we deliberately infected primary human T lymphocytes with amphotropic MLV-based RCR and measured RCR production by the T lymphocytes 1-2 weeks later. Together, our data demonstrate that the capacity of human T lymphocytes to produce amphotropic virions is 2-4 logs lower than that of mouse NIH-3T3 and human 293 cells. In addition, we found that less than 1% of the viral particles produced by primary T lymphocytes are infectious in the PG-4 S þ L-assay. Neutralization of endogenous IFNg did not affect these parameters. After 2 weeks, the total number of infectious viral particles is lower than the number used to infect the cells at the start of the experiment. Thus we conclude that amphotropic MLV-based RCR are produced at very low levels by human primary T lymphocytes.
Results

Specificity of the 4070A env real-time PCR assay
The primer and probe sequences, selected from the 4070A env sequence and designed using the Primer Express software, were used as query sequences in search of sequence databases and were found to be specific for the 4070A env sequence. The specificity of the real-time PCR assay was confirmed by analyzing DNA isolated from known 4070A env-negative and -positive murine and human cells (Table 1) . 4070A env sequences were detected in DNA isolated from the 4070A envpositive cell lines C-CRIP, SFCMM-3 and VR1448, but not in DNA isolated from the 4070A env-negative cell lines C-CRE, GP þ env86, PG13 and Jurkat and in DNA isolated from PBMC from five healthy donors. Gel electrophoresis showed that the real-time PCR products had the correct size of 150 base pairs (data not shown). PCR amplification of the negative samples was possible as demonstrated by normal amplification of endogenous murine T-cell receptor alpha chain constant (Ca) or human albumin genes. Transfection of a 4070A env genecontaining plasmid into Jurkat cells converted the negative PCR signal into a positive one.
Sensitivity of the 4070A env real-time RT-PCR assay
Subsequently, we tested the sensitivity of this assay with two batches of supernatant from the RCR-producer cell line VR-1448. 11 The titers of these batches were determined in the PG-4 S þ L-bioassay and found to be 7.1 Â 10 6 infectious viral particles (ivp)/ml and 4.8 Â 10 6 ivp/ml, respectively (data not shown). Virus was isolated from 1 ml samples of 10-fold serially diluted (10 6 -0.1 ivp/ml) VR-1448 supernatant by ultracentrifugation. RNA was purified from pelleted virus and cDNA was synthesized using random primers. To include an internal control for the efficiency of the various steps, viral supernatants were spiked with 10 ml of a supernatant containing a GALV-pseudotyped second retrovirus encoding the herpes simplex virus thymidine kinase (HSV-TK) gene, prior to centrifugation of the VR-1448 supernatant. 12 cDNA samples were then subjected to duplicate PCR runs for both the 4070A env gene and the HSV-TK gene. The combined results of the HSV-TK-specific PCR showed an average threshold cycle (Ct) value of 24.172.5 (n¼58). The combined results of the 4070A env Ct values of several independent experiments are shown in Figure 1 . All five samples containing 10 ivp or more were positive. Of the 10 samples of 7.0 ivp, nine were positive. Of the five samples of 1.0 ivp, two were positive. Of the 10 samples of 0.7 ivp none was positive, and none of the four samples of 0.1 ivp was positive. Together these data demonstrate that the 4070A env RT-PCR allows detection of very low levels of infectious viral particles. The Ct values of one batch are consistently higher than those of the second batch. This may suggest that the original assessment of the titers has been inaccurate or that one batch contains more noninfectious viral particles than the other.
RCR production by human T lymphocytes
We performed several experiments in which we compared the capacity of primary human T lymphocytes to amplify RCR to the capacity of other cell types. In each experiment, cells were infected with RCR and allowed to amplify those RCR for 1 or 2 weeks. At the end of each experiment, supernatant was harvested and spiked with 10 ml of GALV-pseudotyped HSV-TK-encoding recombinant retrovirus. Virus was isolated, RNA and random primed cDNA was prepared, and both 4070A env-and HSV-TK-specific PCR reactions were carried out in duplicate. In each RT-PCR experiment, a standard range 
Genomic DNA from various cell types, both 4070A env-positive and -negative, as well as the 4070A env-encoding plasmid pAMS were subjected to the 4070A env-specific PCR. Hu, human; mu, murine; NA, not applicable, ND, not done. Table 2A . NIH-3T3 cells produced the highest titers of RCR (0.45 Â 10 6 viral particles (vp)/ml), and T lymphocytes the lowest (0.007 Â 10 6 vp/ml), which is 1.5% of the titer of NIH-3T3 cells. 293 cells produced an RCR titer that was in between that of NIH-3T3 and T lymphocytes (0.065 Â 10 6 vp/ml). The total number of RCR produced by T lymphocytes (0.064 Â 10 6 ) was 0.4% of the total number produced by NIH-3T3 cells. In a second experiment, 1.0 Â 10 5 NIH-3T3, Jurkat and fresh T lymphocytes were infected at MOI 3 and 9 in triplicate and cultured for 14 days, to allow for maximal production of RCR (Table 2B ). The results for the two MOI were comparable. At MOI 3 and 9, NIH-3T3 cells produced 1473 Â 10 6 and 1677 Â 10 6 vp/ml, respectively. The RCR titer produced by Jurkat cells was about half of that of the NIH-3T3 cells, 6.572.1 Â 10 6 and 8.570.2 Â 10 6 vp/ml, respectively. As in the previous experiment, the RCR titers of the T lymphocytes were much lower, 0.00270.003 Â 10 6 (0.02%) and 0.0370.01 Â 10 6 vp/ml (0.2%), respectively. Again, the absolute numbers of RCR produced by T lymphocytes was much lower, compared to NIH-3T3 cells and Jurkat cells.
To analyze the individual variation in RCR production by primary T lymphocytes from different donors, we performed a third experiment in which 2.0 Â 10 5 NIH-3T3, Jurkat cells and primary T lymphocytes of four different donors were again infected at MOI 3 and cultured for 14 days. The results are shown in Table 3 . The RCR production by NIH-3T3 cells was comparable to the previous experiments (10 Â 10 6 vp/ml). In this experiment, Jurkat cells performed less well, producing only 0.9 Â 10 6 vp/ml. 293 cells, which are often used as packaging cells, generated 3.3 Â 10 6 vp/ml. Again, RCR titers produced by primary T lymphocytes were very low and similar for all five donors (1.3-4.3 Â 10 2 vp/ml), with the exception of T lymphocytes from donor 1, which produced a little more (2.0 Â 10 3 vp/ml). Titers of infectious viral particles (ivp) were also determined in this experiment with the PG-4 S þ L-assay. For NIH-3T3 and 293 cells, the titers determined by PCR and in the PG-4 S þ L-assay differed only two-fold. For Jurkat cells, only 4% of total viral particles proved to be infectious. For the primary T lymphocytes, this was even more dramatic. Only one sample, from donor one, was positive in the PG-4 S þ L-assay. The fraction of infectious particles was less than 1% in the culture supernatants of the T lymphocytes from all five donors. Thus, the majority of amphotropic RCR produced by primary T lymphocytes is not infectious.
Next, we analyzed the effect of a neutralizing IFNg antiserum on RCR titers. IFNg, which is produced by T lymphocytes during in vitro expansion, reportedly blocks RCR production. Moreover, the particles produced are largely noninfectious. 13 PBMC were again infected at MOI 3 and cultured for 14 days in the presence of a neutralizing IFNg antiserum, control rabbit IgG or without antibodies. IFNg levels in culture supernatants were 0 on day 7 (data not shown) and between 0 and 10 pg/ml on day 14 ( Figure 2 ). The RCR titers produced by T lymphocytes from all four donors were in the same range and approximately 100-fold higher than in the Human T lymphocytes are poor RCR producers SB Ebeling et al previous experiment (Table 4 ). This may be associated with the relatively high level of proliferation of the T lymphocytes in the latter experiment, compared to the previous one. Reportedly, RCR production is higher in cycling cells than in stationary cells. [14] [15] [16] No effect was observed from the presence of IFNg Ab, either on the total titer of viral particles or on the fraction of infectious viral particles. As in the previous experiment, the fraction of infectious particles was extremely low, at best 0.1% for donor 9. The data suggest that there may be a donor variation with respect to production of infectious viral particles. All three samples from donors 7 and 9 were positive in the PG-4 S þ L-assay, as was the sample from donor 1, while all other samples were negative.
Amplification of RCR
From the data of the last two experiments, we were able to calculate the amplification of infectious RCR by each cell type. For this calculation, we took into account that not all cells had been passaged during the 2-week culture period, to keep the experiments within manageable limits. In addition, virus was isolated from only a fraction of the harvested medium, a fraction of RNA was used for cDNA synthesis, etc. The number of infectious RCR used to infect the cells was divided by the number of infectious RCR produced by the cells after 2 weeks (Table 5 ). For NIH-3T3 cells, we observed a massive amplification of RCR after two weeks. In contrast, primary T lymphocytes produced far less infectious RCR than were used to infect them at the start of the experiment. These data lead us to conclude that amphotropic RCR are not being amplified by human T lymphocytes.
Discussion
Several methods have been described for the detection of RCR. It is generally agreed that amplification of samples on Mus Dunni cells, which themselves do not produce endogenous retroviral-like RNA molecules, followed by the PG-4 S þ L-assay is the preferred method since most types of viruses will be detected, independent of the type of envelope they express. For practical reasons, PCR and ELISA assays have been developed to monitor patients after treatment with retrovirally modified cells. 17, 18 Our quantitative RT-PCR assay is able to detect a single amphotropic RCR. Comparison of the Ct values with those obtained with a standard range of RCR allows calculation of viral titers. For screening of supernatants, spiking with a different retroviral vector, in our case GALV-typed HSV-TK-encoding vector, provides an internal control that allows a reliable comparison between different samples. However, PCR does not discriminate between infectious and noninfectious viral particles and thus may lead to an overestimation of RCR produced. Nevertheless, it is appropriate as a first screening. Positive samples may then be further analyzed in a biological assay. One should realize that PCR analysis of recombinant retroviral supernatant may lead to false-positive samples, due to the presence of genomic DNA from the virus-producing cell line. 17 In that case, inclusion of a DNA control is warranted. In fact, co- Table 2 . For practical reasons, only aliquots of the cells were passaged during the 14-day culture period. The titer of total amphotropic viral particles was determined by RT-PCR (RT-PCR titer). The titer of infectious viral particles was determined in the PG-4 S+L-assay (PG-4 S+L-titer). In the fourth column, the number of infectious viral particles is divided by the number of total viral particles. Figure 2 Effective neutralization of T lymphocyte-derived IFNg. PBMC were cultured for 2 weeks without RCR infection (uninfected) or after infection of 10 5 cells with RCR at MOI 3 at day 2 (RCR), followed by the addition of neutralizing IFNg antiserum (RCR þ aIFNg) or control rabbit serum (RCR þ rabbit IgG). Fresh antiserum was added every time the cells were passaged. After 2 weeks, the presence of IFNg in the culture supernatants was measured via ELISA. The experiment from Table 3 was repeated with cells from additional donors in the absence or presence of neutralizing IFNg antiserum or control rabbit serum (Rab. IgG). For further details, see legend to Table 3 .
Human T lymphocytes are poor RCR producers SB Ebeling et al cultivation of low numbers (10-1000) of the virus, producing cells VR-1448 with T lymphocytes frequently led to positive DNA controls in the PCR in our hands (data not shown). In the experiments described in this report, in which we used VR-1448-derived supernatant rather than the cells themselves, we never observed a positive DNA control. According to the FDA guidelines, RCR testing is required for ex vivo-transduced cells when these are generated in a transduction procedure, which takes more than 3 days. (Guidance for Industry. Supplemental guidance on testing replication competent retrovirus in retroviral vector-based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors, October 2000). This guidance is based on the presumed amplification of RCR, if present in the recombinant viral preparation, during prolonged culture. 19 Our data demonstrate that the extent to which RCR are being amplified depends on the type of cell that is infected. NIH-3T3 and 293 cells have a relatively high capacity (hence their use as virus producing cells). Those cells produce titers of 410 7 vp/ml. In contrast, production of viral particles by T lymphocytes, as determined by RT-PCR, is 2-4 logs lower. In addition, the biological assay showed that less than 1% of the viral particles are infectious. In contrast, the majority if not all viral particles produced by NIH-3T3 and 293 cells are infectious.
Our data confirm those of Cornetta et al, 20 who showed that nine cultures of primary human tumor infiltrating lymphocytes (TIL) obtained from seven different donors produced very low biological titers of RCR. Even 2 months after infection, the titers produced by three of these cultures were only 15712.6 ivp/ml (range 0-40). Additional evidence that monkey T lymphocytes are poor producers of RCR comes from one of the rhesus macaques in the Donahue study that developed lymphoma after RCR infection. This monkey was viremic, and RCR isolated from its serum could be propagated by various cell types of rhesus origin, but not by primate PBMC. 10 Many reports describe the impairment of viral production by interferons, primarily IFNg, through an as yet unknown mechanism.
13,21-23 CD3 stimulation of PBMC leads to a strong induction of IFNa, -b and -g synthesis. By far the majority of the interferon produced is IFNg. Thus it seemed likely that IFNg-mediated inhibition of RCR production was the underlying mechanism for the observed low RCR-production capacity of human T lymphocytes. However, this appeared not to be the case. At this stage it cannot be excluded that the remaining IFNa and Àb are responsible for the observed effects.
The leftover IFNg levels were between 0 and 10 pg/ ml. In experiments in which the effect of IFNg on chronically infected mouse fibroblasts were analyzed, concentrations of 80 U/ml were used. It is hard to judge whether those units are identical to ours. Reportedly, interferon leads to an accumulation of immature virions in the cell. 13 So we analyzed the VR-1448 and infected T cells by electron microscopy. Virions could only be seen in VR-1448 cells, but not in T cells (data not shown). These data support the notion that mechanisms other than those mediated by IFN activity are involved.
Thus, the underlying reason for the poor amplification of RCR by human T lymphocytes is unknown and presently under investigation. It is conceivable that one or more steps in the complex process of virion formation are affected. Numerous replication-defective retroviral mutants have been described, both avian and mamma- Comparison of the production capacity of infectious viral particles by T lymphocytes and NIH-3T3 cells. Amplification of RCR during the culture period could be calculated from the total number of infectious viral particles determined in the PG-4 S+L-assay (output) and the number of infectious viral particles used to infect the cells (input). In the last column, the amplification is represented by the ratio of input ivp and output ivp. ) and references therein. Whatever the cause, we have demonstrated that human T lymphocytes have a very low capacity to produce MLV-based amphotropic RCR. In fact, in all our experiments, the absolute number of RCR used to infect the cells by far exceeded the number of RCR detected after 2 weeks. These observations indicate that T lymphocytes need to be infected with at least 100 ivp in order to lead to detectable numbers after a period of culture of 1 or 2 weeks. With current guidelines on RCR testing of clinical grade batches of recombinant virus, the probability that a small volume (eg 100 ml), which is needed for transduction of T lymphocytes, contains 100 ivp is infinitely small. 19 Of note, a study similar to ours, which addressed the capacity of human T lymphocytes to amplify GALV-typed retrovirus, led to the same conclusion as ours (C Lamers, personal communication). This suggests that ineffective viral amplification by human T lymphocytes may be independent of the type of envelope gene used. If so, these observations may bear relevance on the guidelines for RCR testing of ex vivo-transduced cells.
Materials and methods
Cells
Cell lines were cultured in RPMI 1640 (Gibco) supplemented with antibiotics and 10% FCS (culture medium, CM). PBMC were isolated through Fycoll-Hypaque (Pharmacia Biotech, Uppsala, Sweden) from heparinized blood obtained from healthy donors. RCR-producing VR-1448 cells were obtained from the American Tissue Culture Collection and propagated in CM.
11 VR-1448 cells were cultured to confluence in T75 flasks in CM. Medium was replenished and harvested 1 day later. After filtration through a 0.45 mm filter, aliquots were stored at À801C. The RCR titer was determined in the PG-4 S þ L-assay (see below). PG13 cells producing a recombinant retrovirus encoding the HSV-TK gene together with the truncated low-affinity nerve growth factor receptor were generated and cultured as VR-1448 cells. Supernatant from a confluent culture was harvested and after filtration through a 0.45 mm filter aliquots were stored at À801C.
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PG-4 S þ L-assay
The test was performed according to Bassin et al. 26 Monolayers of Moloney sarcoma virus-transformed Feline Brain cells (PG-4 cells; ATCC CRL 2032) in six-well culture discs were inoculated with 2 ml volumes of sample in the presence of 4 mg/ml polybrene. At 1 day after inoculation, the medium was replaced with McCoy's 5A medium (Gibco BRL) containing 15% FCS and 50 mg/ml gentamycin. After 6-7 days of incubation, the monolayers were fixed with methanol and stained and microscopically observed for the presence of typical foci and plaques.
Infection of cells with RCR
For infection of PBMC with RCR, they were prestimulated by incubation at 1 Â 10 6 cells/ml and 371C in the presence of 10 ng OKT3/ml and 300 IU/ml of human recombinant IL2 (Proleukin, Chiron, Amsterdam, The Netherlands). Cells were infected with RCR in the presence of 6 mg polybrene/ml after 2 days of culture. Cells were harvested and counted every 3-4 days, and further cultured at a concentration of 0.5 Â 10 6 cells/ml in the presence of 300 IU IL2/ml. After infection of Jurkat cells, they were also harvested and counted every 3-4 days and kept at a concentration of 0.5 Â 10 6 cells/ml. Similarly, NIH-3T3 and 293 cells were trypsinized every 3-4 days and diluted 5-to 10-fold for further culture. Thus, each cell type was cultured under conditions most suitable for that cell type to remain in log phase, since RCR is best produced by cells growing in log phase. [14] [15] [16] After the indicated culture time periods, supernatant was harvested and residual cells and cell debris were removed by centrifugation at 500 g for 5 min. Then the supernatant was filtered through a 0.45 mm filter and aliquots were stored at À801C till further use. In experiments where a neutralizing rabbit aIFNg antiserum was used, 27 sufficient antiserum was added to neutralize 50 000 pg IFNg/ml, an estimated 10-fold excess. The antiserum was added on days 0, 3, 6 and 14.
Real-time PCR and RT-PCR
Genomic DNA was isolated with the Puregene DNA isolation kit (Gentra, Minneapolis, MN, USA). Prior to virus isolation from different supernatants of RCRinfected cells, the supernatants were spiked with 10 ml of an HSV-TK-encoding PG13 supernatant to provide an internal control. Virus was then isolated from 1 ml of supernatants by centrifugation for 1 h at 26 500 g at 41C. For RNA isolation,the pellet was resuspended in 1 ml of Trizol (Life Technologies, Gaithersburg, MD, USA) and purification of RNA was performed according to the manufacturer's instructions. Purified RNA was resuspended in 30 ml dH 2 0 and stored at À801C till further use. For cDNA synthesis, 8 ml of RNA was used and cDNA was synthesized using random primers and the Roche cDNA synthesis kit (Indianapolis, IN, USA) according to the manufacturer's instructions. Each 20-ml cDNA reaction mixture contained 2 ml of 10 Â RT buffer, 5.0 mM MgCl 2 , 250 mM of each deoxynucleotide triphosphate, 2.5 mM random hexamer, 50 U of RNase inhibitor and 20 U of RT. After incubation for 3 min at 851C, RT was carried out at 421C for 1.5 h. The cDNA was stored at À201C till further use. Primers and probes for the HSV-TK-and 4070A env-specific PCR reactions were selected using Primer Express software (PE Applied Biosystems). For the HSV-TK-specific PCR, the following primers and probe were used: forward GTACCCGAGCCGATGACT TACT, reverse GCCAGCACGGCCCT, probe CTTCCGA GACAATCGCGAACATCTACACACACAACA. For the 4070A env-specific PCR, the following primers and probe were used: forward 5 0 CAACCTGATGACTGGGCGTA 3 0 , reverse 5 0 CTTGCAGCCATACCCGACAT 3 0 , probe 5 0 TCGGAGAGGAGTGGGACCCTTCAGAC 3 0 . Both probes consisted of oligonucleotides with the 5 0 reporter dye 6-carboxyfluorescein (FAM) and the 3 0 quencher dye 6-carboxytetramethylrhodamine (TAMRA). For amplification of HSV-TK and 4070A env sequences, duplicate Human T lymphocytes are poor RCR producers SB Ebeling et al PCR samples (25 ml) were set up with 0.5 mg DNA or 5 ml cDNA, 20 ml Taqman universal PCR master mix containing ROX as a passive reference (PE Applied Biosystems), 300 nM of each primer, 200 nM probe and 4 mM MgCl 2 . Amplification and detection were performed with an ABI Prism 7700 sequence detection system under the following conditions: 10 min at 951C to activate AmpliTaq Gold DNA polymerase, and 45 cycles of 15 s at 951C and 1 min at 601C. During amplification, the ABI Prism sequence detector monitored real-time PCR amplification by quantitatively analyzing fluorescence emissions. The reporter dye (FAM) signal was measured against the internal reference dye (ROX) signal to normalize for non-PCR-related fluorescence fluctuations occurring from well to well. The Ct represented the refraction cycle number at which a positive amplification reaction was measured and was set at 10 times the standard deviation of the mean baseline emission calculated for PCR cycles 3-15.
Calculation of RCR titer based on PCR data
In PCR assays of individual RCR-infection experiments, a 10-fold serially diluted range (10 6 -0.1 ivp/ml) of RCR was included as a standard curve. Each of these samples had also been spiked with 10 ml of HSV-TK-containing PG13 supernatant. The average Ct value of the HSV-TK-PCR was calculated for all samples of the standard RCR range. This value was then compared to the Ct values of the HSV-TK-PCR of the culture supernatants. This comparison allowed a correction (for input material and efficiency of virus and RNA isolation and cDNA synthesis) of the 4070A env Ct values of the supernatant samples. The corrected 4070A env PCR Ct values of each supernatant sample was then interpolated on the RCR standard curve to calculate an RCR titer.
